Longevity Acquisition Corporation Ordinary Shares
LOAC
LOAC was delisted on the 19th of March, 2021.
0 hedge funds and large institutions have $0 invested in Longevity Acquisition Corporation Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.
12.93% less ownership
Funds ownership: 12.93% → 0% (-13%)
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $4.05M → $0 (-$4.05M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$2.43M |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$1.21M |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
-$238K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$125K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$48K |
LOAC Hedge Fund Activity: Q1 2021 in Review
0 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Ordinary Shares (LOAC) for Q1 2021, worth a combined $0 — down 100% from $4.05M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LOAC and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Glazer Capital LLC, exiting entirely with an estimated $2.43M sold.
- 0 institutional investors held Longevity Acquisition Corporation Ordinary Shares (LOAC) as of Q1 2021, down from 8 in Q4 2020.
- Funds reported $0 of Longevity Acquisition Corporation Ordinary Shares stock for Q1 2021, down 100% quarter-over-quarter.
- 0 funds opened new Longevity Acquisition Corporation Ordinary Shares positions in Q1 2021 and 8 closed out, a net change of -8 holders.
- The largest Longevity Acquisition Corporation Ordinary Shares seller in Q1 2021 was Glazer Capital LLC, an estimated $2.43M sold.
Based on aggregated 13F filings for Q1 2021.